Den Haag, Netherlands

Tiemen Geert Pieter Reijns



Average Co-Inventor Count = 4.6

ph-index = 1


Location History:

  • The Hague, NL (2009)
  • Den Haag, NL (2011)

Company Filing History:


Years Active: 2009-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tiemen Geert Pieter Reijns: Innovating Antibiotic Technologies

Introduction

Tiemen Geert Pieter Reijns is a distinguished inventor based in Den Haag, Netherlands. With a focus on developing innovative healthcare solutions, he holds a total of three patents that contribute to advancements in antibiotic therapies. His work primarily revolves around glycopeptide compositions, which have shown promise in enhancing antibiotic efficacy.

Latest Patents

Reijns' recent patents include a groundbreaking invention titled "Glycopeptide composition with improved antibiotic activity." This patent outlines a novel glycopeptide composition, along with a method for its preparation. The aim of this invention is to improve antibiotic activity, making it a significant addition to the pharmaceutical field. Reijns has demonstrated remarkable consistency and dedication in his research, with this patent being a repeat disclosure for emphasis on its importance.

Career Highlights

Throughout his career, Tiemen Geert Pieter Reijns has made impactful contributions while working for notable companies such as Xellia Pharmaceuticals and Axellia Pharmaceuticals. His expertise in the pharmaceutical industry has allowed him to play a pivotal role in the development of antibiotics and the fight against bacterial infections.

Collaborations

During his professional journey, Reijns has collaborated with skilled colleagues, including Anita Mathiesen and Torben Koch. These partnerships have facilitated the exchange of ideas and expertise, further enriching the research and development processes in which they are involved.

Conclusion

Tiemen Geert Pieter Reijns stands as a testament to the spirit of innovation in the pharmaceutical industry. His contributions through his patents and collaborative efforts are helping to pave the way for more effective antibiotic solutions, ultimately benefiting public health and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…